| Ligand | Protein Symbol | Approved Name | Docking Scores |
Similarity Score |
Best Match | ||
|---|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | |||||
| pmi | 5HT1B_HUMAN | 5-hydroxytryptamine receptor 1B | -8.04 | -8.01 | -6.89 | 43.66% | CHEMBL2424668 |
| mi | 5HT1B_HUMAN | 5-hydroxytryptamine receptor 1B | -8.09 | -8.96 | -7.75 | 56.12% | CHEMBL111107 |
| 7mi | 5HT1B_HUMAN | 5-hydroxytryptamine receptor 1B | -7.80 | -9.03 | -7.44 | 32.29% | CHEMBL305837 |
| pmi | 5HT2A_HUMAN | 5-hydroxytryptamine receptor 2A | -7.85 | -6.30 | N/A | 54.41% | CHEMBL3233149 |
| mi | 5HT2A_HUMAN | 5-hydroxytryptamine receptor 2A | -8.74 | -7.93 | N/A | 49.73% | CHEMBL267615 |
| 7mi | 5HT2A_HUMAN | 5-hydroxytryptamine receptor 2A | -7.65 | -7.56 | N/A | 41.24% | CHEMBL1277311 |
| pmi | 5HT2B_HUMAN | 5-hydroxytryptamine receptor 2B | -7.51 | -8.08 | -8.04 | 57.39% | CHEMBL3947432 |
| mi | 5HT2B_HUMAN | 5-hydroxytryptamine receptor 2B | -8.59 | -8.88 | -9.03 | 76.88% | CHEMBL15245 |
| 7mi | 5HT2B_HUMAN | 5-hydroxytryptamine receptor 2B | -7.67 | -8.12 | -8.25 | 37.63% | CHEMBL1277312 |
| pmi | 5HT2C_HUMAN | 5-hydroxytryptamine receptor 2C | -8.27 | -7.76 | N/A | 52.97% | CHEMBL3907399 |
| mi | 5HT2C_HUMAN | 5-hydroxytryptamine receptor 2C | -8.85 | -8.33 | N/A | 53.14% | CHEMBL553794 |
| 7mi | 5HT2C_HUMAN | 5-hydroxytryptamine receptor 2C | -8.71 | -7.89 | N/A | 37.63% | CHEMBL1277312 |
| pmi | AA1R_HUMAN | adenosine A1 receptor | -7.54 | -8.09 | -4.82 | 37.67% | CHEMBL3350613 |
| mi | AA1R_HUMAN | adenosine A1 receptor | -8.06 | -8.96 | -5.52 | 41.31% | CHEMBL411329 |
| 7mi | AA1R_HUMAN | adenosine A1 receptor | -7.17 | -7.99 | -5.75 | 35.02% | CHEMBL3317575 |
| pmi | AA2AR_HUMAN | adenosine A2a receptor | -7.44 | -6.91 | -8.42 | 44.33% | CHEMBL539454 |
| mi | AA2AR_HUMAN | adenosine A2a receptor | -7.80 | -7.73 | -7.29 | 51.04% | CHEMBL3929822 |
| 7mi | AA2AR_HUMAN | adenosine A2a receptor | -6.56 | -6.25 | -5.83 | 35.02% | CHEMBL3317575 |
| pmi | ACES_HUMAN | acetylcholinesterase (Cartwright blood group) | -9.77 | -8.32 | -6.94 | 52.75% | CHEMBL306776 |
| mi | ACES_HUMAN | acetylcholinesterase (Cartwright blood group) | -9.34 | -8.98 | -7.50 | 65.16% | CHEMBL452240 |
| 7mi | ACES_HUMAN | acetylcholinesterase (Cartwright blood group) | -8.71 | -9.02 | -7.05 | 38.57% | CHEMBL3417004 |
| pmi | ACE_HUMAN | angiotensin I converting enzyme | -8.46 | -8.39 | -7.88 | 47.34% | CHEMBL417169 |
| mi | ACE_HUMAN | angiotensin I converting enzyme | -8.63 | -8.56 | -7.87 | 52.53% | CHEMBL148616 |
| 7mi | ACE_HUMAN | angiotensin I converting enzyme | -8.41 | -8.50 | -7.11 | 32.31% | CHEMBL311471 |
| pmi | ACHA9_HUMAN | cholinergic receptor nicotinic alpha 9 subunit | -6.71 | N/A | N/A | 31.73% | CHEMBL386114 |
| mi | ACHA9_HUMAN | cholinergic receptor nicotinic alpha 9 subunit | -7.05 | N/A | N/A | 36.00% | CHEMBL386114 |
| 7mi | ACHA9_HUMAN | cholinergic receptor nicotinic alpha 9 subunit | -6.82 | N/A | N/A | 27.17% | CHEMBL386114 |
| pmi | ACHB2_HUMAN | cholinergic receptor nicotinic beta 2 subunit | -1.42 | -4.72 | -3.31 | N/A | N/A |
| mi | ACHB2_HUMAN | cholinergic receptor nicotinic beta 2 subunit | -1.05 | -3.09 | -1.85 | N/A | N/A |
| 7mi | ACHB2_HUMAN | cholinergic receptor nicotinic beta 2 subunit | -0.03 | -3.31 | -2.52 | N/A | N/A |
| pmi | ACM1_HUMAN | cholinergic receptor muscarinic 1 | -6.70 | 4.76 | N/A | 45.36% | CHEMBL1243109 |
| mi | ACM1_HUMAN | cholinergic receptor muscarinic 1 | -6.45 | 7.35 | N/A | 47.31% | CHEMBL318995 |
| 7mi | ACM1_HUMAN | cholinergic receptor muscarinic 1 | -3.12 | 7.80 | N/A | 36.89% | CHEMBL96042 |
| pmi | ACM4_HUMAN | cholinergic receptor muscarinic 4 | -5.74 | -5.28 | N/A | 41.94% | CHEMBL3354077 |
| mi | ACM4_HUMAN | cholinergic receptor muscarinic 4 | -6.11 | -5.18 | N/A | 54.29% | CHEMBL105160 |
| 7mi | ACM4_HUMAN | cholinergic receptor muscarinic 4 | -7.05 | -5.39 | N/A | 35.79% | CHEMBL3085495 |
| pmi | ADRB2_HUMAN | adrenoceptor beta 2 | -6.67 | -7.11 | -8.31 | 41.55% | CHEMBL1814270 |
| mi | ADRB2_HUMAN | adrenoceptor beta 2 | -7.01 | -7.83 | -9.31 | 45.75% | CHEMBL236042 |
| 7mi | ADRB2_HUMAN | adrenoceptor beta 2 | -7.44 | -6.40 | -8.42 | 37.23% | CHEMBL1714856 |
| pmi | AGTR2_HUMAN | angiotensin II receptor type 2 | -7.67 | -8.09 | -7.70 | 43.75% | CHEMBL406907 |
| mi | AGTR2_HUMAN | angiotensin II receptor type 2 | -7.83 | -8.08 | -7.63 | 43.59% | CHEMBL154057 |
| 7mi | AGTR2_HUMAN | angiotensin II receptor type 2 | -8.04 | -8.53 | -8.42 | 34.82% | CHEMBL154057 |
| pmi | ALDR_HUMAN | aldo-keto reductase family 1 member B | -7.67 | -7.08 | -7.36 | 35.50% | CHEMBL281620 |
| mi | ALDR_HUMAN | aldo-keto reductase family 1 member B | -7.95 | -7.44 | -7.30 | 52.63% | CHEMBL1944855 |
| 7mi | ALDR_HUMAN | aldo-keto reductase family 1 member B | -7.78 | -6.99 | -7.59 | 36.10% | CHEMBL71562 |
| pmi | AMPN_HUMAN | alanyl aminopeptidase, membrane | -7.82 | -8.42 | -8.22 | 42.04% | CHEMBL1797983 |
| mi | AMPN_HUMAN | alanyl aminopeptidase, membrane | -8.23 | -8.19 | -8.23 | 57.52% | CHEMBL1077585 |
| 7mi | AMPN_HUMAN | alanyl aminopeptidase, membrane | -7.61 | -7.49 | -7.47 | 31.72% | CHEMBL1077585 |
| pmi | AOFA_HUMAN | monoamine oxidase A | -7.78 | -9.35 | -7.44 | 47.89% | CHEMBL4073457 |
| mi | AOFA_HUMAN | monoamine oxidase A | -8.77 | -8.67 | -8.32 | 49.32% | CHEMBL2333926 |
| 7mi | AOFA_HUMAN | monoamine oxidase A | -8.75 | -8.72 | -7.66 | 37.44% | CHEMBL4073457 |
| pmi | AOFB_HUMAN | monoamine oxidase B | -7.44 | -7.70 | -7.43 | 40.93% | CHEMBL3093176 |
| mi | AOFB_HUMAN | monoamine oxidase B | -8.66 | -8.47 | -8.60 | 49.32% | CHEMBL2333926 |
| 7mi | AOFB_HUMAN | monoamine oxidase B | -8.66 | -8.44 | -8.13 | 34.25% | CHEMBL1796445 |
| pmi | BACE1_HUMAN | beta-secretase 1 | -7.01 | -7.20 | -8.25 | 52.29% | CHEMBL256399 |
| mi | BACE1_HUMAN | beta-secretase 1 | -7.30 | -8.18 | -8.35 | 48.70% | CHEMBL3907751 |
| 7mi | BACE1_HUMAN | beta-secretase 1 | -7.35 | -7.98 | -8.12 | 35.47% | CHEMBL3910708 |
| pmi | CAH2_HUMAN | carbonic anhydrase 2 | -8.28 | -8.13 | -7.69 | 38.57% | CHEMBL3885091 |
| mi | CAH2_HUMAN | carbonic anhydrase 2 | -7.79 | -7.74 | -7.02 | 44.93% | CHEMBL2335178 |
| 7mi | CAH2_HUMAN | carbonic anhydrase 2 | -6.96 | -6.45 | -6.38 | 34.62% | CHEMBL306510 |
| pmi | CASP1_HUMAN | caspase 1 | -6.41 | -7.07 | -6.17 | 51.18% | CHEMBL114791 |
| mi | CASP1_HUMAN | caspase 1 | -5.90 | -7.02 | -6.10 | 45.10% | CHEMBL1221643 |
| 7mi | CASP1_HUMAN | caspase 1 | -5.96 | -6.42 | -6.04 | 34.01% | CHEMBL248309 |
| pmi | CDK5_HUMAN | cyclin dependent kinase 5 | -7.53 | -6.46 | -5.55 | 36.71% | CHEMBL1992125 |
| mi | CDK5_HUMAN | cyclin dependent kinase 5 | -7.33 | -6.45 | -7.28 | 46.45% | CHEMBL2005528 |
| 7mi | CDK5_HUMAN | cyclin dependent kinase 5 | -7.21 | -7.03 | -4.94 | 30.43% | CHEMBL2000393 |
| pmi | CHLE_HUMAN | butyrylcholinesterase | -8.43 | -8.13 | -8.46 | 40.50% | CHEMBL210453 |
| mi | CHLE_HUMAN | butyrylcholinesterase | -8.57 | -8.62 | -8.77 | 56.81% | CHEMBL382260 |
| 7mi | CHLE_HUMAN | butyrylcholinesterase | -8.34 | -8.20 | -8.53 | 34.23% | CHEMBL210453 |
| pmi | CNR1_HUMAN | cannabinoid receptor 1 | -7.63 | -8.81 | -5.84 | 47.92% | CHEMBL445022 |
| mi | CNR1_HUMAN | cannabinoid receptor 1 | -7.13 | -7.40 | -9.05 | 57.20% | CHEMBL445022 |
| 7mi | CNR1_HUMAN | cannabinoid receptor 1 | -6.84 | -6.23 | -6.95 | 40.00% | CHEMBL409927 |
| pmi | CNR2_HUMAN | cannabinoid receptor 2 | -8.04 | -9.05 | N/A | 43.58% | CHEMBL3234036 |
| mi | CNR2_HUMAN | cannabinoid receptor 2 | -9.12 | -9.73 | N/A | 52.78% | CHEMBL2029729 |
| 7mi | CNR2_HUMAN | cannabinoid receptor 2 | -6.15 | -8.24 | N/A | 39.47% | CHEMBL1765247 |
| pmi | COLI_HUMAN | proopiomelanocortin | -7.67 | -7.68 | -6.20 | N/A | N/A |
| mi | COLI_HUMAN | proopiomelanocortin | -7.77 | -7.82 | -7.31 | N/A | N/A |
| 7mi | COLI_HUMAN | proopiomelanocortin | -8.10 | -6.69 | -6.21 | N/A | N/A |
| pmi | COMT_HUMAN | catechol-O-methyltransferase | -6.45 | -6.30 | -5.55 | 32.86% | CHEMBL3819488 |
| mi | COMT_HUMAN | catechol-O-methyltransferase | -6.50 | -6.06 | -5.25 | 37.66% | CHEMBL3425740 |
| 7mi | COMT_HUMAN | catechol-O-methyltransferase | -6.10 | -5.69 | -5.28 | 28.76% | CHEMBL3819488 |
| pmi | CRP_HUMAN | C-reactive protein | -6.02 | -5.71 | N/A | N/A | N/A |
| mi | CRP_HUMAN | C-reactive protein | -5.79 | -5.67 | N/A | N/A | N/A |
| 7mi | CRP_HUMAN | C-reactive protein | -5.72 | -5.59 | N/A | N/A | N/A |
| pmi | CXCR1_HUMAN | C-X-C motif chemokine receptor 1 | 3.18 | N/A | N/A | 41.25% | CHEMBL556862 |
| mi | CXCR1_HUMAN | C-X-C motif chemokine receptor 1 | 0.28 | N/A | N/A | 32.45% | CHEMBL556862 |
| 7mi | CXCR1_HUMAN | C-X-C motif chemokine receptor 1 | 1.21 | N/A | N/A | 28.89% | CHEMBL556862 |
| pmi | CXCR4_HUMAN | C-X-C motif chemokine receptor 4 | -8.19 | -6.96 | -8.00 | 43.32% | CHEMBL1256583 |
| mi | CXCR4_HUMAN | C-X-C motif chemokine receptor 4 | -8.73 | -7.27 | -8.43 | 56.59% | CHEMBL1644072 |
| 7mi | CXCR4_HUMAN | C-X-C motif chemokine receptor 4 | -8.09 | -7.00 | -7.27 | 35.25% | CHEMBL3894327 |
| pmi | DRD2_HUMAN | dopamine receptor D2 | -7.11 | N/A | N/A | 52.97% | CHEMBL159742 |
| mi | DRD2_HUMAN | dopamine receptor D2 | -7.31 | N/A | N/A | 76.88% | CHEMBL15245 |
| 7mi | DRD2_HUMAN | dopamine receptor D2 | -7.12 | N/A | N/A | 38.92% | CHEMBL1774101 |
| pmi | DRD3_HUMAN | dopamine receptor D3 | -8.09 | N/A | N/A | 47.73% | CHEMBL136961 |
| mi | DRD3_HUMAN | dopamine receptor D3 | -7.75 | N/A | N/A | 52.86% | CHEMBL136711 |
| 7mi | DRD3_HUMAN | dopamine receptor D3 | -7.75 | N/A | N/A | 53.31% | CHEMBL517730 |
| pmi | DRD4_HUMAN | dopamine receptor D4 | -8.15 | -8.24 | N/A | 52.97% | CHEMBL159742 |
| mi | DRD4_HUMAN | dopamine receptor D4 | -7.69 | -8.92 | N/A | 45.75% | CHEMBL310867 |
| 7mi | DRD4_HUMAN | dopamine receptor D4 | -8.52 | -8.28 | N/A | 37.00% | CHEMBL126361 |
| pmi | EDN1_HUMAN | endothelin 1 | -7.62 | N/A | N/A | N/A | N/A |
| mi | EDN1_HUMAN | endothelin 1 | -7.26 | N/A | N/A | N/A | N/A |
| 7mi | EDN1_HUMAN | endothelin 1 | -7.87 | N/A | N/A | N/A | N/A |
| pmi | ESR1_HUMAN | estrogen receptor 1 | -6.72 | -5.71 | -5.40 | 40.19% | CHEMBL3360850 |
| mi | ESR1_HUMAN | estrogen receptor 1 | -6.92 | -6.70 | -6.55 | 56.19% | CHEMBL3623001 |
| 7mi | ESR1_HUMAN | estrogen receptor 1 | -5.39 | -6.15 | -6.99 | 38.57% | CHEMBL3360850 |
| pmi | FABP5_HUMAN | fatty acid binding protein 5 | -8.20 | -5.98 | -5.93 | 30.25% | CHEMBL3971182 |
| mi | FABP5_HUMAN | fatty acid binding protein 5 | -8.56 | -5.97 | -5.80 | 30.28% | CHEMBL3959018 |
| 7mi | FABP5_HUMAN | fatty acid binding protein 5 | -7.59 | -5.59 | -6.06 | 25.53% | CHEMBL247920 |
| pmi | FYN_HUMAN | FYN proto-oncogene, Src family tyrosine kinase | -6.60 | N/A | N/A | 36.71% | CHEMBL1992125 |
| mi | FYN_HUMAN | FYN proto-oncogene, Src family tyrosine kinase | -7.07 | N/A | N/A | 36.82% | CHEMBL470808 |
| 7mi | FYN_HUMAN | FYN proto-oncogene, Src family tyrosine kinase | -6.98 | N/A | N/A | 31.38% | CHEMBL1999749 |
| pmi | GLRA3_HUMAN | glycine receptor alpha 3 | -8.02 | -7.75 | -7.87 | 32.23% | CHEMBL4070615 |
| pmi | GLRA3_HUMAN | glycine receptor alpha 3 | -8.82 | N/A | N/A | 32.23% | CHEMBL4070615 |
| mi | GLRA3_HUMAN | glycine receptor alpha 3 | -8.09 | -8.65 | -7.96 | 32.27% | CHEMBL4070615 |
| mi | GLRA3_HUMAN | glycine receptor alpha 3 | -9.83 | N/A | N/A | 32.27% | CHEMBL4070615 |
| 7mi | GLRA3_HUMAN | glycine receptor alpha 3 | -7.35 | -7.36 | -8.41 | 23.75% | CHEMBL4070615 |
| 7mi | GLRA3_HUMAN | glycine receptor alpha 3 | -9.50 | N/A | N/A | 23.75% | CHEMBL4070615 |
| pmi | GRM5_HUMAN | glutamate metabotropic receptor 5 | -0.71 | -1.04 | 1.26 | 36.89% | CHEMBL3915745 |
| mi | GRM5_HUMAN | glutamate metabotropic receptor 5 | -4.44 | -1.46 | -2.39 | 49.37% | CHEMBL3672913 |
| 7mi | GRM5_HUMAN | glutamate metabotropic receptor 5 | -5.23 | 1.80 | -3.80 | 32.72% | CHEMBL3122225 |
| pmi | HPGDS_HUMAN | hematopoietic prostaglandin D synthase | -7.09 | -7.08 | -6.05 | 38.70% | CHEMBL3698267 |
| mi | HPGDS_HUMAN | hematopoietic prostaglandin D synthase | -7.51 | -7.26 | -6.04 | 37.50% | CHEMBL3650208 |
| 7mi | HPGDS_HUMAN | hematopoietic prostaglandin D synthase | -7.58 | -6.37 | -6.87 | 31.13% | CHEMBL3134496 |
| pmi | HRH1_HUMAN | histamine receptor H1 | -2.86 | N/A | N/A | 44.12% | CHEMBL1277492 |
| mi | HRH1_HUMAN | histamine receptor H1 | -4.68 | N/A | N/A | 49.52% | CHEMBL1783966 |
| 7mi | HRH1_HUMAN | histamine receptor H1 | -4.01 | N/A | N/A | 41.24% | CHEMBL1277311 |
| pmi | HYES_HUMAN | epoxide hydrolase 2 | -7.86 | -8.17 | -7.32 | 40.31% | CHEMBL3818537 |
| mi | HYES_HUMAN | epoxide hydrolase 2 | -8.12 | -8.35 | -7.97 | 43.50% | CHEMBL1077963 |
| 7mi | HYES_HUMAN | epoxide hydrolase 2 | -7.91 | -8.31 | -8.56 | 39.82% | CHEMBL482845 |
| pmi | IKKB_HUMAN | inhibitor of nuclear factor kappa B kinase subunit beta | -5.85 | N/A | N/A | 40.98% | CHEMBL3823257 |
| mi | IKKB_HUMAN | inhibitor of nuclear factor kappa B kinase subunit beta | -6.49 | N/A | N/A | 39.92% | CHEMBL181756 |
| 7mi | IKKB_HUMAN | inhibitor of nuclear factor kappa B kinase subunit beta | -6.19 | N/A | N/A | 33.04% | CHEMBL3823257 |
| pmi | MDR1_HUMAN | ATP binding cassette subfamily B member 1 | -9.23 | -7.71 | N/A | 47.92% | CHEMBL445022 |
| mi | MDR1_HUMAN | ATP binding cassette subfamily B member 1 | -8.75 | -8.16 | N/A | 70.18% | CHEMBL772 |
| 7mi | MDR1_HUMAN | ATP binding cassette subfamily B member 1 | -7.03 | -7.65 | N/A | 37.10% | CHEMBL223354 |
| pmi | MIF_HUMAN | macrophage migration inhibitory factor | -5.07 | -5.67 | -5.53 | 34.13% | CHEMBL2375651 |
| mi | MIF_HUMAN | macrophage migration inhibitory factor | -5.47 | -5.92 | -5.35 | 30.65% | CHEMBL2375651 |
| 7mi | MIF_HUMAN | macrophage migration inhibitory factor | -4.98 | -5.75 | -4.98 | 34.33% | CHEMBL554271 |
| pmi | MK01_HUMAN | mitogen-activated protein kinase 1 | -6.69 | -7.37 | -7.83 | 40.19% | CHEMBL3398606 |
| mi | MK01_HUMAN | mitogen-activated protein kinase 1 | -7.12 | -7.50 | -7.62 | 50.22% | CHEMBL3422092 |
| 7mi | MK01_HUMAN | mitogen-activated protein kinase 1 | -6.35 | -7.51 | -7.03 | 37.63% | CHEMBL332551 |
| pmi | MK03_HUMAN | mitogen-activated protein kinase 3 | -6.77 | -7.09 | -6.69 | 35.47% | CHEMBL3590107 |
| mi | MK03_HUMAN | mitogen-activated protein kinase 3 | -7.05 | -8.25 | -7.52 | 35.51% | CHEMBL3798926 |
| 7mi | MK03_HUMAN | mitogen-activated protein kinase 3 | -6.32 | -7.36 | -6.87 | 29.28% | CHEMBL3798926 |
| pmi | MTOR_HUMAN | mechanistic target of rapamycin kinase | -8.67 | -8.64 | -8.84 | 37.39% | CHEMBL1259120 |
| mi | MTOR_HUMAN | mechanistic target of rapamycin kinase | -8.70 | -8.61 | -8.81 | 40.99% | CHEMBL2334763 |
| 7mi | MTOR_HUMAN | mechanistic target of rapamycin kinase | -8.58 | -8.24 | -8.81 | 33.74% | CHEMBL411735 |
| pmi | NEP_HUMAN | membrane metalloendopeptidase | -7.42 | -7.31 | -7.36 | 45.05% | CHEMBL2112402 |
| mi | NEP_HUMAN | membrane metalloendopeptidase | -8.10 | -8.06 | -7.25 | 50.68% | CHEMBL305388 |
| 7mi | NEP_HUMAN | membrane metalloendopeptidase | -7.14 | -7.19 | -7.18 | 39.25% | CHEMBL284818 |
| pmi | NK1R_HUMAN | tachykinin receptor 1 | -7.64 | -7.01 | -7.25 | 50.00% | CHEMBL423254 |
| mi | NK1R_HUMAN | tachykinin receptor 1 | -8.32 | -7.64 | -7.35 | 50.45% | CHEMBL1766207 |
| 7mi | NK1R_HUMAN | tachykinin receptor 1 | -7.53 | -6.82 | -7.25 | 39.56% | CHEMBL286640 |
| pmi | NMDE1_HUMAN | glutamate ionotropic receptor NMDA type subunit 2A | -8.14 | -7.54 | -7.27 | 20.30% | CHEMBL284237 |
| mi | NMDE1_HUMAN | glutamate ionotropic receptor NMDA type subunit 2A | -8.67 | -8.12 | -8.25 | 28.79% | CHEMBL284237 |
| 7mi | NMDE1_HUMAN | glutamate ionotropic receptor NMDA type subunit 2A | -7.21 | -7.18 | -7.30 | 18.31% | CHEMBL284237 |
| pmi | NMDE2_HUMAN | glutamate ionotropic receptor NMDA type subunit 2B | -7.86 | -7.47 | -7.98 | 34.08% | CHEMBL3357789 |
| mi | NMDE2_HUMAN | glutamate ionotropic receptor NMDA type subunit 2B | -7.65 | -7.75 | -6.66 | 40.47% | CHEMBL2013201 |
| 7mi | NMDE2_HUMAN | glutamate ionotropic receptor NMDA type subunit 2B | -6.85 | -7.16 | -7.66 | 32.16% | CHEMBL3357783 |
| pmi | NMDZ1_HUMAN | glutamate ionotropic receptor NMDA type subunit 1 | -8.10 | -7.42 | -7.27 | 31.76% | CHEMBL162577 |
| mi | NMDZ1_HUMAN | glutamate ionotropic receptor NMDA type subunit 1 | -8.66 | -8.02 | -8.25 | 38.10% | CHEMBL162577 |
| 7mi | NMDZ1_HUMAN | glutamate ionotropic receptor NMDA type subunit 1 | -7.13 | -7.22 | -7.30 | 28.03% | CHEMBL354003 |
| pmi | NOS1_HUMAN | nitric oxide synthase 1 | -7.92 | -7.74 | -8.89 | 39.09% | CHEMBL3216558 |
| mi | NOS1_HUMAN | nitric oxide synthase 1 | -7.23 | -7.29 | -8.15 | 37.07% | CHEMBL4097898 |
| 7mi | NOS1_HUMAN | nitric oxide synthase 1 | -7.69 | -7.70 | -7.15 | 44.85% | CHEMBL85823 |
| pmi | NOS2_HUMAN | nitric oxide synthase 2 | -6.97 | -8.60 | -6.23 | 37.84% | CHEMBL220213 |
| mi | NOS2_HUMAN | nitric oxide synthase 2 | -4.80 | -8.12 | -5.09 | 38.70% | CHEMBL1911986 |
| 7mi | NOS2_HUMAN | nitric oxide synthase 2 | -5.28 | -7.67 | -4.78 | 41.51% | CHEMBL162416 |
| pmi | NTRK1_HUMAN | neurotrophic receptor tyrosine kinase 1 | -6.32 | -7.47 | -8.24 | 39.07% | CHEMBL3934925 |
| mi | NTRK1_HUMAN | neurotrophic receptor tyrosine kinase 1 | -7.79 | -7.85 | -7.63 | 44.59% | CHEMBL2003524 |
| 7mi | NTRK1_HUMAN | neurotrophic receptor tyrosine kinase 1 | -8.44 | -8.48 | -8.20 | 35.96% | CHEMBL3890360 |
| pmi | OPRD_HUMAN | opioid receptor delta 1 | -7.66 | -7.29 | -6.72 | 100.00% | CHEMBL58362 |
| mi | OPRD_HUMAN | opioid receptor delta 1 | -7.08 | -6.88 | -6.92 | 100.00% | CHEMBL299031 |
| 7mi | OPRD_HUMAN | opioid receptor delta 1 | -6.92 | -6.73 | -6.89 | 100.00% | CHEMBL61630 |
| pmi | OPRK_HUMAN | opioid receptor kappa 1 | -9.63 | -7.50 | -9.00 | 100.00% | CHEMBL58362 |
| mi | OPRK_HUMAN | opioid receptor kappa 1 | -9.54 | -7.85 | -8.41 | 57.71% | CHEMBL226113 |
| 7mi | OPRK_HUMAN | opioid receptor kappa 1 | -8.73 | -7.54 | -7.64 | 48.10% | CHEMBL58362 |
| pmi | OPRM_MOUSE | Mu-type opioid receptor | -7.87 | -8.01 | N/A | 48.33% | CHEMBL3216579 |
| mi | OPRM_MOUSE | Mu-type opioid receptor | -8.24 | -8.04 | N/A | 53.69% | CHEMBL1929366 |
| 7mi | OPRM_MOUSE | Mu-type opioid receptor | -7.61 | -7.71 | N/A | 36.99% | CHEMBL3339378 |
| pmi | OPRX_HUMAN | opioid related nociceptin receptor 1 | -7.24 | -7.46 | -7.42 | 49.48% | CHEMBL2064143 |
| mi | OPRX_HUMAN | opioid related nociceptin receptor 1 | -7.41 | -7.16 | -7.36 | 64.02% | CHEMBL3326229 |
| 7mi | OPRX_HUMAN | opioid related nociceptin receptor 1 | -7.47 | -7.30 | -7.59 | 37.77% | CHEMBL233493 |
| pmi | P2RX3_HUMAN | purinergic receptor P2X 3 | -5.73 | -5.57 | -5.68 | 50.68% | CHEMBL3679816 |
| mi | P2RX3_HUMAN | purinergic receptor P2X 3 | -5.59 | -5.52 | -5.61 | 43.18% | CHEMBL3679838 |
| 7mi | P2RX3_HUMAN | purinergic receptor P2X 3 | -5.57 | -5.49 | -6.02 | 40.26% | CHEMBL3669736 |
| pmi | P2Y12_HUMAN | purinergic receptor P2Y12 | -7.52 | -3.18 | -7.80 | 38.35% | CHEMBL2172143 |
| mi | P2Y12_HUMAN | purinergic receptor P2Y12 | -7.56 | -5.08 | -7.05 | 43.60% | CHEMBL3652613 |
| 7mi | P2Y12_HUMAN | purinergic receptor P2Y12 | -6.63 | -3.90 | -6.72 | 32.30% | CHEMBL2172144 |
| pmi | PAR1_HUMAN | coagulation factor II thrombin receptor | -5.90 | N/A | N/A | 41.67% | CHEMBL3658403 |
| mi | PAR1_HUMAN | coagulation factor II thrombin receptor | -6.48 | N/A | N/A | 42.23% | CHEMBL433499 |
| 7mi | PAR1_HUMAN | coagulation factor II thrombin receptor | -6.83 | N/A | N/A | 33.78% | CHEMBL80942 |
| pmi | PDE4B_HUMAN | phosphodiesterase 4B | -7.28 | -8.25 | -8.85 | 40.41% | CHEMBL3944139 |
| mi | PDE4B_HUMAN | phosphodiesterase 4B | -7.93 | -8.56 | -8.92 | 50.00% | CHEMBL290191 |
| 7mi | PDE4B_HUMAN | phosphodiesterase 4B | -8.26 | -8.61 | -8.93 | 40.23% | CHEMBL505431 |
| pmi | PDE5A_HUMAN | phosphodiesterase 5A | -6.84 | -6.98 | -7.28 | 34.69% | CHEMBL3930444 |
| mi | PDE5A_HUMAN | phosphodiesterase 5A | -7.97 | -7.89 | -8.29 | 57.32% | CHEMBL509728 |
| 7mi | PDE5A_HUMAN | phosphodiesterase 5A | -8.05 | -7.79 | -7.26 | 34.41% | CHEMBL188461 |
| pmi | PERM_HUMAN | myeloperoxidase | -7.85 | -7.95 | -7.75 | 30.29% | CHEMBL3920217 |
| mi | PERM_HUMAN | myeloperoxidase | -7.60 | -7.53 | -7.61 | 39.18% | CHEMBL3929246 |
| 7mi | PERM_HUMAN | myeloperoxidase | -7.34 | -7.31 | -7.30 | 29.11% | CHEMBL490 |
| pmi | PGH1_SHEEP | Prostaglandin G/H synthase 1 | -3.05 | -6.66 | -5.29 | 33.33% | CHEMBL9192 |
| mi | PGH1_SHEEP | Prostaglandin G/H synthase 1 | -2.49 | -5.06 | -5.34 | 48.43% | CHEMBL24798 |
| 7mi | PGH1_SHEEP | Prostaglandin G/H synthase 1 | -3.89 | -5.47 | -3.72 | 27.43% | CHEMBL47687 |
| pmi | PGH2_HUMAN | prostaglandin-endoperoxide synthase 2 | 3.73 | -3.10 | -6.44 | 38.12% | CHEMBL15039 |
| mi | PGH2_HUMAN | prostaglandin-endoperoxide synthase 2 | 0.02 | -2.50 | -6.88 | 49.77% | CHEMBL281457 |
| 7mi | PGH2_HUMAN | prostaglandin-endoperoxide synthase 2 | 1.50 | 1.80 | -6.68 | 31.56% | CHEMBL4089144 |
| pmi | PPAP_HUMAN | acid phosphatase 3 | -7.31 | N/A | N/A | 20.67% | CHEMBL507996 |
| mi | PPAP_HUMAN | acid phosphatase 3 | -8.08 | N/A | N/A | 22.90% | CHEMBL507996 |
| 7mi | PPAP_HUMAN | acid phosphatase 3 | -7.61 | N/A | N/A | 18.72% | CHEMBL507996 |
| pmi | PPARG_HUMAN | peroxisome proliferator activated receptor gamma | -8.11 | -5.66 | -8.87 | 49.07% | CHEMBL343215 |
| mi | PPARG_HUMAN | peroxisome proliferator activated receptor gamma | -7.72 | -7.22 | -8.14 | 54.04% | CHEMBL1836978 |
| 7mi | PPARG_HUMAN | peroxisome proliferator activated receptor gamma | -6.93 | -5.50 | -6.72 | 36.70% | CHEMBL3317865 |
| pmi | PRGR_HUMAN | progesterone receptor | -4.78 | -6.03 | -8.74 | 50.25% | CHEMBL219314 |
| mi | PRGR_HUMAN | progesterone receptor | -6.44 | -7.11 | -8.27 | 55.35% | CHEMBL3623003 |
| 7mi | PRGR_HUMAN | progesterone receptor | -7.05 | -7.00 | -8.00 | 40.18% | CHEMBL286029 |
| pmi | PTGES_HUMAN | prostaglandin E synthase | -7.87 | N/A | N/A | 40.50% | CHEMBL4084995 |
| mi | PTGES_HUMAN | prostaglandin E synthase | -5.91 | N/A | N/A | 45.49% | CHEMBL3770829 |
| 7mi | PTGES_HUMAN | prostaglandin E synthase | -5.94 | N/A | N/A | 33.04% | CHEMBL4078000 |
| pmi | SC6A4_HUMAN | solute carrier family 6 member 4 | -9.83 | -9.29 | -9.73 | 49.73% | CHEMBL3233427 |
| mi | SC6A4_HUMAN | solute carrier family 6 member 4 | -9.43 | -9.34 | -9.11 | 54.77% | CHEMBL294481 |
| 7mi | SC6A4_HUMAN | solute carrier family 6 member 4 | -9.34 | -8.97 | -9.57 | 41.80% | CHEMBL574081 |
| pmi | SCN9A_HUMAN | sodium voltage-gated channel alpha subunit 9 | -6.46 | N/A | N/A | 53.52% | CHEMBL247829 |
| mi | SCN9A_HUMAN | sodium voltage-gated channel alpha subunit 9 | -6.18 | N/A | N/A | 49.57% | CHEMBL3617060 |
| 7mi | SCN9A_HUMAN | sodium voltage-gated channel alpha subunit 9 | -7.09 | N/A | N/A | 42.13% | CHEMBL569285 |
| pmi | TLR4_HUMAN | toll like receptor 4 | -7.47 | -7.58 | -7.18 | 33.16% | CHEMBL1223752 |
| mi | TLR4_HUMAN | toll like receptor 4 | -8.19 | -6.59 | -6.91 | 39.24% | CHEMBL3261254 |
| 7mi | TLR4_HUMAN | toll like receptor 4 | -7.02 | -6.76 | -7.30 | 33.04% | CHEMBL382272 |
| pmi | TNFA_HUMAN | tumor necrosis factor | -8.02 | N/A | N/A | 43.03% | CHEMBL2337619 |
| mi | TNFA_HUMAN | tumor necrosis factor | -7.62 | N/A | N/A | 46.15% | CHEMBL2337619 |
| 7mi | TNFA_HUMAN | tumor necrosis factor | -7.49 | N/A | N/A | 38.11% | CHEMBL2337617 |
| pmi | TRBM_HUMAN | thrombomodulin | -7.06 | -7.45 | N/A | N/A | N/A |
| mi | TRBM_HUMAN | thrombomodulin | -7.50 | -6.96 | N/A | N/A | N/A |
| 7mi | TRBM_HUMAN | thrombomodulin | -7.60 | -6.16 | N/A | N/A | N/A |
| pmi | TRPM4_HUMAN | transient receptor potential cation channel subfamily M member 4 | -6.65 | -6.18 | N/A | N/A | N/A |
| mi | TRPM4_HUMAN | transient receptor potential cation channel subfamily M member 4 | -7.11 | -6.81 | N/A | N/A | N/A |
| 7mi | TRPM4_HUMAN | transient receptor potential cation channel subfamily M member 4 | -8.00 | -6.28 | N/A | N/A | N/A |
| pmi | TRPM8_FICAL | Uncharacterized protein | -8.27 | N/A | N/A | N/A | N/A |
| mi | TRPM8_FICAL | Uncharacterized protein | -9.01 | N/A | N/A | N/A | N/A |
| 7mi | TRPM8_FICAL | Uncharacterized protein | -9.13 | N/A | N/A | N/A | N/A |
| pmi | TRPV1_RAT | Transient receptor potential cation channel subfamily V member 1 | -6.42 | N/A | N/A | 52.72% | CHEMBL3114906 |
| mi | TRPV1_RAT | Transient receptor potential cation channel subfamily V member 1 | -7.99 | N/A | N/A | 58.29% | CHEMBL438345 |
| 7mi | TRPV1_RAT | Transient receptor potential cation channel subfamily V member 1 | -6.73 | N/A | N/A | 36.86% | CHEMBL3114907 |
| pmi | TRPV2_RABIT | Transient receptor potential cation channel subfamily V member 2 | -7.11 | -6.48 | N/A | N/A | N/A |
| mi | TRPV2_RABIT | Transient receptor potential cation channel subfamily V member 2 | -6.76 | -8.57 | N/A | N/A | N/A |
| 7mi | TRPV2_RABIT | Transient receptor potential cation channel subfamily V member 2 | -6.17 | -7.37 | N/A | N/A | N/A |
| pmi | TRPV3_HUMAN | transient receptor potential cation channel subfamily V member 3 | -6.42 | -7.09 | N/A | 38.89% | CHEMBL3664218 |
| mi | TRPV3_HUMAN | transient receptor potential cation channel subfamily V member 3 | -6.37 | -6.73 | N/A | 42.72% | CHEMBL3696459 |
| 7mi | TRPV3_HUMAN | transient receptor potential cation channel subfamily V member 3 | -6.32 | -6.16 | N/A | 38.57% | CHEMBL3664218 |
| pmi | TRXR1_HUMAN | thioredoxin reductase 1 | -8.47 | -7.91 | -6.69 | N/A | N/A |
| mi | TRXR1_HUMAN | thioredoxin reductase 1 | -7.62 | -7.54 | -6.63 | N/A | N/A |
| 7mi | TRXR1_HUMAN | thioredoxin reductase 1 | -7.85 | -7.49 | -6.54 | N/A | N/A |
| pmi | TRY1_HUMAN | serine protease 1 | -6.02 | N/A | N/A | 44.96% | CHEMBL87502 |
| mi | TRY1_HUMAN | serine protease 1 | -5.80 | N/A | N/A | 47.58% | CHEMBL3973384 |
| 7mi | TRY1_HUMAN | serine protease 1 | -5.42 | N/A | N/A | 38.03% | CHEMBL45106 |